ArticleFrontiers in psychiatry2026
Analysis of factors influencing anxiety and depression disorders among hospitalized patients.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Novel anxiolytic-antidepressant combinations TF-1 and TF-2 and their intervention mechanisms in a mouse model of comorbid anxiety and depression (CAD).Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As globally prevalent mental health conditions, anxiety and depression impose significant socioeconomic burdens on healthcare systems. Key risk factors for anxiety and depression were determined in the current study by examining the associations across multiple domains. Methods: Participants were enrolled for this cross-sectional study from the Department of Gerontology at the Fifth Affiliated Hospital of Sun Yat-sen University in 2023. Anxiety and depression were evaluated based on the Hamilton Anxiety (HAM-A) and Hamilton Depression (HAMD) Rating Scales, respectively. Cognitive function, sleep quality, frailty, and nutritional status were evaluated using the Montreal Cognitive Assessment (MoCA), the Pittsburgh Sleep Quality Index (PSQI), the FRAIL scale, and the Nutrition Risk Screening (NRS)-2002, respectively. Multiple linear regression analysis was performed to determine the factors associated with anxiety and depression. Results: A total of 1121 participants (659 women and 462 men; mean age ± SD: 64.67 ± 10.86 years) were studied. HAMD scores were significantly associated with gender (β = 0.078, Conclusions: Male patients with superior physical and cognitive function, better sleep, favorable body mass index and nutrition status, and fewer illnesses had better mood. Targeted interventions, including cognitive preservation, sleep optimization, frailty prevention, comorbidity management, and lifestyle modification, may be correlated with reduced symptom burden. Special consideration is warranted for elderly and female populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.